Forbes contributors publish independent expert analyses and insights. I show you how to save and invest. The Federal Open Market Committee is expected to move interest rates lower in 2026, but not ...

Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...

Monitoring the interest rate climate for homebuyers and owners hoping to refinance can easily become a daily activity. And in the interest rate climate of recent years, it was often a disappointing ...

The Federal Reserve cut interest rates by a quarter point on Wednesday, as it was widely expected to, lowering borrowing costs for the third time since September. The latest cut brings the target ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

President Trump has repeatedly called for lower rates since he took office. President Donald Trump this week renewed his call for lower interest rates after a fresh inflation reading came in lower ...

Allowing your money to grow over time is one of the best ways to build wealth. It's possible to reach $1 million by steadily investing a portion of your income. Most experts recommend saving 15% of ...

Rallybio has agreed to sell its interest in a drug-development plan seeking to treat a rare genetic bone disease to its joint-venture partner Recursion Pharmaceuticals for up to $25 million. The New ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – Rallybio Corporation (Nasdaq: RLYB), a ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

With compounding, your money grows -- and the amount by which it grows also grows. Compounding can help you get to a million dollars -- or more. These 10 Stocks Could Mint the Next Wave of ...